Meet entrepreneurs, engineers, surgeons and other key players in the ecosystem at the Fifth Annual Rosenman Symposium, a half-day conference held at the UCSF Mission Bay campus on Wednesday, June 20.
Registration is free. Join the 450+ who have already registered by reserving your spot today.
The symposium, a forum for the growing health technology community in San Francisco, features leading speakers from industry, and lightning pitches by founders of selected startups.
The event is produced by the Rosenman Institute, a University of California initiative based at UCSF Mission Bay. The institute helps entrepreneurs commercialize medical device technologies by forging connections with resources such as legal help, mentoring, funding, and industry partners.
Featured speakers include Benson Smith, Chairman, Teleflex; Tejal Desai, Chair, Department of Bioengineering & Therapeutic Sciences, UC San Francisco; Joe DeSimone, CEO & Co-Founder, Carbon; Jeffrey Shuren, Director, Center for Devices & Radiological Health, FDA; and Andrew Thompson, CEO, Proteus Digital Health.
The symposium presentations will conclude with a panel discussion, “The Future of Innovation in Health Technologies: Aligning All the Stakeholders,” moderated by Josh Makower, General Partner, NEA. Panel members include Tim Homer, VP Global Health Policy, Reimbursement & Government Relations, Avedro; Wende Hutton, General Partner, Canaan Partners; Kate Rosenbluth, CEO & Co-Founder, Cala Health; Renee Compton Ryan, VP, Venture Investments, J&J Innovation; and the FDA’s Jeffrey Shuren.
Through the afternoon, attendees will hear rapid presentations from the Rosenman Innovators: the founders of 10 startups selected in the 2018 cycle of a yearly competition to receive in-kind services from top providers and introductions to investors and industry partners.
A networking reception with speakers, founders, and attendees follows the presentations.
The Rosenman Symposium is sponsored by Brown Rudnick, iO lifescience, MedTech Venture Partners, Nipro, J&J Innovation JJDC, and Silicon Valley Bank. The symposium partner is UCSF-Stanford CERSI and the media partner is Medgadget.
About the Rosenman Institute
The Rosenman Institute is the health technology initiative of QB3, the University of California’s hub for entrepreneurship in life science. The Institute’s mission is to drive medical device innovation and education and improve patient care by helping entrepreneurs develop technologies from concept to commercialization. Visit http://rosenmaninstitute.org/